The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologists physical status class I-II and scheduled for an elective robot-assisted laparoscopic radical prostatectomy or robot-assisted laparoscopic radical cystectomy
- Patients who voluntarily decides to participate in the trial and has agreed in written informed consent
Exclusion Criteria:
- Patients with the anatomical abnormalities of respiratory system(abnormal airway anatomy, severe scoliosis, post-pneumonectomy state), severe chronic respiratory diseases, chronic obstructive pulmonary disease (COPD), asthma, heart failure, obesity ( Body Mass Index [BMI] > 30kg/m2), severe hepatic failure or renal failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1:2, 1:1 group
Inspiratory to expiratory time ratio (I:E ratio) of 1:2 during the first one hour of laparoscopy and then switched to I:E ratio of 1:1 during the rest time of laparoscopy.
|
Adjustment of Mechanical Ventilator Inspiratory to expiratory time ratio (1:2 to 1:1)
|
|
Active Comparator: 1:1, 1:2 group
Inspiratory to expiratory time ratio (I:E ratio) of 1:1 during the first one hour of laparoscopy and then switched to I:E ratio of 1:2 during the rest time of laparoscopy.
|
Adjustment of Mechanical Ventilator Inspiratory to expiratory time ratio (1:1 to 1:2)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 5 minutes after anesthesia induction
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
5 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 5 minutes after anesthesia induction
|
PaO2 (arterial partial pressure of oxygen)
|
5 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 60 minutes after anesthesia induction
|
PaO2 (arterial partial pressure of oxygen)
|
60 minutes after anesthesia induction
|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 120 minutes after anesthesia induction
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
120 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
PaO2 (arterial partial pressure of oxygen)
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 10 min after restoration of supine position
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
10 min after restoration of supine position
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 10 min after restoration of supine position
|
PaO2 (arterial partial pressure of oxygen)
|
10 min after restoration of supine position
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 5 minutes after anesthesia induction
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
5 minutes after anesthesia induction
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
oxygen index
Time Frame: 5 minutes after anesthesia induction
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
5 minutes after anesthesia induction
|
|
oxygen index
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
oxygen index
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
Alveolar-arterial oxygen difference
Time Frame: 5 minutes after anesthesia induction
|
5 minutes after anesthesia induction
|
|
|
Alveolar-arterial oxygen difference
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
|
Alveolar-arterial oxygen difference
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Kim MS, Kim NY, Lee KY, Choi YD, Hong JH, Bai SJ. The impact of two different inspiratory to expiratory ratios (1:1 and 1:2) on respiratory mechanics and oxygenation during volume-controlled ventilation in robot-assisted laparoscopic radical prostatectomy: a randomized controlled trial. Can J Anaesth. 2015 Sep;62(9):979-87. doi: 10.1007/s12630-015-0383-2. Epub 2015 Apr 14.
- Gainsburg DM. Anesthetic concerns for robotic-assisted laparoscopic radical prostatectomy. Minerva Anestesiol. 2012 May;78(5):596-604. Epub 2012 Mar 13.
- De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93(4):373-83. doi: 10.1159/000366008. Epub 2014 Sep 23.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1609-102-793
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.